Gary Pace
Directeur/Membre du Conseil chez CARDIFF ONCOLOGY, INC.
Fortune : 3 M $ au 31/05/2024
Profil
Dr. Gary W.
Pace is an Independent Director at Cardiff Oncology, Inc., a Chairman at Sova Pharmaceuticals, Inc., a Partner & Investment Committee Chair at Pacific Channel Ltd., an Independent Director at Pacira Biosciences, Inc., an Executive Chairman at View Point Medical, Inc. and a Professor at The University of Queensland.
He is on the Board of Directors at Cardiff Oncology, Inc., Pacira Biosciences, Inc., Curtana Pharmaceuticals, Inc., Immunicom, Inc., NeuroMedix, Inc., Protiveris, Inc., Sacron Innovations Pty Ltd.
and Upstream Medical Technologies Ltd.
Dr. Pace was previously employed as an Independent Non-Executive Director by Invitrocue Ltd., an Independent Non-Executive Director by Simavita Ltd., an Independent Non-Executive Director by Antisense Therapeutics Ltd., an Independent Director by Transition Therapeutics, Inc., an Independent Non-Executive Director by QRxPharma Ltd., a Chairman & Chief Executive Officer by Waratah Pharmaceuticals, Inc., a President & Chief Executive Officer by RTP Pharma, Inc, an Independent Director by ResMed, Inc., a Founder by Transcend Therapeutics, Inc., a Senior Vice President-Research & Development by Clintec, and a Vice Chairman by Hunter Immunology Pty Ltd.
He also served on the board at Engender Technologies Ltd., Footfalls & Heartbeats (UK) Ltd., Peplin, Inc., Peplin Ltd., Celsion Corp., AVACEN, Inc. and Breathe Easy Ltd.
He received his undergraduate degree from The University of New South Wales and a doctorate degree from Massachusetts Institute of Technology.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CARDIFF ONCOLOGY, INC.
1,56% | 22/04/2024 | 697 761 ( 1,56% ) | 2 M $ | 31/05/2024 |
PACIRA BIOSCIENCES, INC.
0,05% | 15/04/2024 | 22 127 ( 0,05% ) | 671 112 $ | 31/05/2024 |
| 17/11/2022 | 1 236 138 ( 0,14% ) | 66 591 $ | 31/05/2024 |
Postes actifs de Gary Pace
| Sociétés | Poste | Début |
|---|---|---|
| PACIRA BIOSCIENCES, INC. | Directeur/Membre du Conseil | 01/06/2008 |
| CARDIFF ONCOLOGY, INC. | Directeur/Membre du Conseil | 22/04/2020 |
Upstream Medical Technologies Ltd.
 Upstream Medical Technologies Ltd. BiotechnologyHealth Technology Upstream Medical Technologies Ltd. engages in the commercialization of novel biomarkers for cardiac disease diagnosis. It focuses on the identification of patients with unstable angina. The company was founded by Chris Pemberton in 2015 and is headquartered in Christchurch, New Zealand. | Directeur/Membre du Conseil | - |
Curtana Pharmaceuticals, Inc.
 Curtana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Curtana Pharmaceuticals, Inc. is a preclinical-stage biopharmaceutical company, which engages in the provision of therapies for the treatment of brain cancer. It focuses on the development of small molecule therapeutics targeting cancer stem cells in the central nervous system for the treatment of glioblastoma and other brain cancers. The company was founded by Gregory Stein in 2013 and is headquartered in Austin, TX. | Directeur/Membre du Conseil | - |
View Point Medical, Inc.
 View Point Medical, Inc. Pharmaceuticals: MajorHealth Technology View Point Medical, Inc. engages in the provision of medical device and technology focuses on surgical outcomes using novel tissue markers that enable lesion localization in cancer care. It offers SignalMark platform. The company was founded by William Blair and Jeffrey Port and is headquartered in Carlsbad, CA. | Président | - |
Immunicom, Inc.
 Immunicom, Inc. Medical SpecialtiesHealth Technology Immunicom, Inc. engages in the development, clinical and regulatory affairs, manufacturing, and global commercialization of medical devices and pharmacologic therapies. It specializes in the treatment approach of cancer, inflammatory diseases, and autoimmune diseases. The company was founded by Amir Jafri and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | - |
| Sacron Innovations Pty Ltd. | Directeur/Membre du Conseil | - |
Sova Pharmaceuticals, Inc.
 Sova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sova Pharmaceuticals, Inc. engages in the discovery and development of human therapeutic drugs. It provides internal clinical plan on therapies supported by the mechanism, our preclinical findings, and the development of compounds reported to act on the molecular targets of H2S that include postherpetic neuralgia, chemotherapy induced peripheral neuropathic pain (CIPN pain) and diabetic neuropathy. The company’s pre-clinical findings support large-market indications, such as osteoarthritis, rheumatoid arthritis, neuropathic pain and migraine, that we would seek to develop with a strategic partner. The company was founded by Gary W. Pace and Solomon Snyder in 2010 and is headquartered in La Jolla, CA. | Fondateur | 03/11/2010 |
| Protiveris, Inc. | Directeur/Membre du Conseil | - |
| ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Anciens postes connus de Gary Pace
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Gary Pace
| Massachusetts Institute of Technology | Doctorate Degree |
| The University of New South Wales | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| RESMED, INC. | Health Technology |
| IMUNON, INC. | Health Technology |
| PERCHERON THERAPEUTICS LIMITED | Health Technology |
| PACIRA BIOSCIENCES, INC. | Health Technology |
| CARDIFF ONCOLOGY, INC. | Health Technology |
| Entreprise privées | 24 |
|---|---|
Transcend Therapeutics, Inc.
 Transcend Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Transcend Therapeutics, Inc. develops and markets pharmaceutical products. It offers its products for oxidative stress, cytokine dysfunction, and multiple organ dysfunctions. The company was founded by Dennis I. Goldberg and Gary W. Pace in 1992 and is headquartered in Cambridge, MA. | Health Technology |
| Protiveris, Inc. | |
Transition Therapeutics, Inc.
 Transition Therapeutics, Inc. Medical SpecialtiesHealth Technology Transition Therapeutics, Inc. develops novel therapeutics for disease indications. It operates through research and development of therapeutic agents segment. The firm's products include ELND005 for the treatment of alzheimer's disease, bipolar disorder and down syndrome. Its metabolic drug candidate is TT401 for treatment of type 2 diabetes and accompanying obesity. Transition Therapeutics was founded by Tony F. Cruz on July 6, 1998 and is headquartered in Toronto, Canada. | Health Technology |
Waratah Pharmaceuticals, Inc.
 Waratah Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Part of OPKO Health, Inc., Waratah Pharmaceuticals, Inc. develops pharmaceutical products. The company is based in Calgary, Canada. The Canadian company was founded by Susan Dana Jones. Waratah Pharmaceuticals was acquired by Transition Therapeutics, Inc., part of OPKO Health, Inc. from September 01, 2016 on January 28, 2002 for $15.46 million. | Health Technology |
Peplin Ltd.
 Peplin Ltd. Pharmaceuticals: OtherHealth Technology Peplin Ltd. provides development and commercialisation of prescription human therapeutic products for the treatment of cancer. It also provides drug development process, clinical development and pre-clinical development services. It was was founded in 1998 and is located in Newstead, Australia | Health Technology |
NeuroMedix, Inc.
 NeuroMedix, Inc. Pharmaceuticals: MajorHealth Technology NeuroMedix, Inc. develops pharmaceutical products. The company makes therapeutic agents for the treatment of degenerative and inflammatory diseases of the central nervous system, such as Alzheimer's disease and multiple sclerosis. It also develops therapies for the treatment of other degenerative neuroinflammatory diseases, such as Parkinson's. NeuroMedix was founded in 2005 and is headquartered in Toronto, Canada. | Health Technology |
Guardian Medical Solutions Ltd.
 Guardian Medical Solutions Ltd. Pharmaceuticals: MajorHealth Technology Guardian Medical Solutions Ltd. engages in the development and commercialization of biopharmaceutical products. The company was founded by Michael Anthony Quinn and Felix de la Iglesia on September 19, 2002 and is headquartered in Sydney, Australia. | Health Technology |
Peplin, Inc.
 Peplin, Inc. Pharmaceuticals: MajorHealth Technology Peplin, Inc. develops drugs and pharmaceutical products. The company was founded by James Harrison Aylward in 1998 and is headquartered in Emeryville, CA. | Health Technology |
Invitrocue Ltd.
 Invitrocue Ltd. Medical/Nursing ServicesHealth Services Invitrocue Ltd. engages in the provision of bio analytic solutions including in vitro cell-based testing technologies and image analytics software for use in digital pathology. The firm focuses on the commercialization of its bio analytics services using cell based model and imaging based technology. The company was founded by Steven Fang Boon Sing and Hanry Yu in 2012 and is headquartered in Sydney, Australia. | Health Services |
Clintec International, Inc. (Illinois)
 Clintec International, Inc. (Illinois) Pharmaceuticals: MajorHealth Technology Part of Baxter International, Inc., Clintec International, Inc. is a pharmaceutical company based in Deerfield, IL. The company specializes in the development and distribution of pharmaceutical products. | Health Technology |
SkyePharma Canada, Inc.
 SkyePharma Canada, Inc. Miscellaneous Commercial ServicesCommercial Services SkyePharma Canada, Inc. improves the solubility of drugs through the use of nano-particulate technology. The company is based in Verdun, Canada. SkyePharma Canada was acquired by SkyePharma Plc on March 13, 2002 for $20.01 million. | Commercial Services |
Hunter Immunology Pty Ltd.
 Hunter Immunology Pty Ltd. Medical SpecialtiesHealth Technology Hunter Immunology Ltd. operates as a biotechnology company. It develops immune modulators for treatment of respiratory diseases. The company was founded by Phillip Comans in 2003 and is headquartered in Victoria, Australia. | Health Technology |
Sova Pharmaceuticals, Inc.
Sova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sova Pharmaceuticals, Inc. engages in the discovery and development of human therapeutic drugs. It provides internal clinical plan on therapies supported by the mechanism, our preclinical findings, and the development of compounds reported to act on the molecular targets of H2S that include postherpetic neuralgia, chemotherapy induced peripheral neuropathic pain (CIPN pain) and diabetic neuropathy. The company’s pre-clinical findings support large-market indications, such as osteoarthritis, rheumatoid arthritis, neuropathic pain and migraine, that we would seek to develop with a strategic partner. The company was founded by Gary W. Pace and Solomon Snyder in 2010 and is headquartered in La Jolla, CA. | Health Technology |
Breathe Easy Ltd.
 Breathe Easy Ltd. Medical/Nursing ServicesHealth Services Breathe Easy Ltd. develops drug for cystic fibrosis. It is developing an inhaled medicine called Citramel, as a core therapy to improve lung function and to potentially enhance the effectiveness of other inhaled CF therapies such as antibiotics. The company was founded on April 30, 2009 by Brent Stuart Ogilvie, Robert bartlett Elliott and Andrea Miller and is headquartered in Auckland, New Zealand. | Health Services |
Pacific Channel Ltd.
 Pacific Channel Ltd. Investment ManagersFinance Pacific Channel Ltd (Pacific Channel) is a venture capital firm founded in 2006 by Brent S. Ogilvie. The firm is headquartered in Auckland, New Zealand. | Finance |
| Sacron Innovations Pty Ltd. | |
Simavita Ltd.
 Simavita Ltd. Information Technology ServicesTechnology Services Simavita Ltd. is a MedTec company. It is focused on the development of smart, wearable and disposable platform technologies for the health care market. The firm operates through the Australia and Rest of the World geographical segments. The company was founded on May 28, 1968 and is headquartered in North Sydney, Australia. | Technology Services |
Footfalls & Heartbeats (UK) Ltd.
 Footfalls & Heartbeats (UK) Ltd. TextilesProcess Industries Footfalls & Heartbeats (UK) Ltd. designs, develops, and manufactures smart textiles. The firm uses nano-scale interactions within the textile to make the fabric itself the sensor, avoiding the need for wires or miniature electronics. The company was founded by Simon McMaster in 2010 and is headquartered in Nottingham, the United Kingdom. | Process Industries |
Engender Technologies Ltd.
 Engender Technologies Ltd. Medical/Nursing ServicesHealth Services Engender Technologies Ltd. engages in the research and development of gender selection especially in the dairy industry. The company was founded by Miriam Cather Simpson on October 6, 2011 and is headquartered in Auckland, New Zealand. | Health Services |
Upstream Medical Technologies Ltd.
Upstream Medical Technologies Ltd. BiotechnologyHealth Technology Upstream Medical Technologies Ltd. engages in the commercialization of novel biomarkers for cardiac disease diagnosis. It focuses on the identification of patients with unstable angina. The company was founded by Chris Pemberton in 2015 and is headquartered in Christchurch, New Zealand. | Health Technology |
View Point Medical, Inc.
View Point Medical, Inc. Pharmaceuticals: MajorHealth Technology View Point Medical, Inc. engages in the provision of medical device and technology focuses on surgical outcomes using novel tissue markers that enable lesion localization in cancer care. It offers SignalMark platform. The company was founded by William Blair and Jeffrey Port and is headquartered in Carlsbad, CA. | Health Technology |
Immunicom, Inc.
Immunicom, Inc. Medical SpecialtiesHealth Technology Immunicom, Inc. engages in the development, clinical and regulatory affairs, manufacturing, and global commercialization of medical devices and pharmacologic therapies. It specializes in the treatment approach of cancer, inflammatory diseases, and autoimmune diseases. The company was founded by Amir Jafri and is headquartered in San Diego, CA. | Health Technology |
Curtana Pharmaceuticals, Inc.
Curtana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Curtana Pharmaceuticals, Inc. is a preclinical-stage biopharmaceutical company, which engages in the provision of therapies for the treatment of brain cancer. It focuses on the development of small molecule therapeutics targeting cancer stem cells in the central nervous system for the treatment of glioblastoma and other brain cancers. The company was founded by Gregory Stein in 2013 and is headquartered in Austin, TX. | Health Technology |
AVACEN, Inc.
 AVACEN, Inc. Medical SpecialtiesHealth Technology Avacen, Inc. provides non-invasive medical device that provides temporary relief for arthritis, muscle and joint pain. The company was founded by Thomas G. Muehlbauer and Danielle J Forsgren in 2008 and is headquartered in San Diego, CA. | Health Technology |
